Parnax Lab Limited (PARNAXLAB.BO)
INR 105.7
(1.63%)
INR 105.7
(1.63%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 787.61 Million INR | 47.38% |
| 2022 | 534.39 Million INR | -17.42% |
| 2021 | 647.11 Million INR | 10.2% |
| 2020 | 587.2 Million INR | 15.5% |
| 2019 | 508.4 Million INR | 21.08% |
| 2018 | 419.9 Million INR | 17.71% |
| 2017 | 356.71 Million INR | -8.93% |
| 2016 | 391.68 Million INR | -1.65% |
| 2015 | 398.25 Million INR | 2.91% |
| 2014 | 387 Million INR | 30.33% |
| 2013 | 296.95 Million INR | 30.69% |
| 2012 | 227.2 Million INR | -14.57% |
| 2011 | 265.97 Million INR | 57175.58% |
| 2010 | 464.37 Thousand INR | 763.19% |
| 2009 | -70.02 Thousand INR | -173.68% |
| 2008 | -25.58 Thousand INR | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | - INR | -100.0% |
| 2023 FY | 787.61 Million INR | 47.38% |
| 2023 Q3 | 22.4 Million INR | -96.15% |
| 2023 Q2 | 581.4 Million INR | 1990.65% |
| 2023 Q4 | 787.61 Million INR | 3415.21% |
| 2023 Q1 | 27.81 Million INR | -94.8% |
| 2022 Q1 | 57.81 Million INR | -91.07% |
| 2022 FY | 534.39 Million INR | -17.42% |
| 2022 Q4 | 534.39 Million INR | 2518.05% |
| 2022 Q3 | 20.41 Million INR | -96.53% |
| 2022 Q2 | 587.6 Million INR | 916.44% |
| 2021 Q4 | 647.11 Million INR | 4481.33% |
| 2021 FY | 647.11 Million INR | 10.2% |
| 2021 Q2 | 630.41 Million INR | 4880.79% |
| 2021 Q1 | 12.65 Million INR | -97.84% |
| 2021 Q3 | 14.12 Million INR | -97.76% |
| 2020 Q1 | 3.86 Million INR | -99.24% |
| 2020 Q2 | 481.17 Million INR | 12338.87% |
| 2020 FY | 587.2 Million INR | 15.5% |
| 2020 Q3 | 15.51 Million INR | -96.77% |
| 2020 Q4 | 587.2 Million INR | 3683.76% |
| 2019 Q4 | 508.4 Million INR | 4847.03% |
| 2019 FY | 508.4 Million INR | 21.08% |
| 2019 Q2 | 397.01 Million INR | 6568.02% |
| 2019 Q3 | 10.27 Million INR | -97.41% |
| 2019 Q1 | 5.95 Million INR | -98.58% |
| 2018 Q2 | 303.68 Million INR | 0.0% |
| 2018 Q3 | 15.92 Million INR | -94.76% |
| 2018 Q4 | 419.9 Million INR | 2536.43% |
| 2018 FY | 419.9 Million INR | 17.71% |
| 2017 FY | 356.71 Million INR | -8.93% |
| 2017 Q4 | 356.71 Million INR | 0.0% |
| 2017 Q1 | 4.33 Million INR | -98.7% |
| 2016 Q3 | 5.49 Million INR | -98.49% |
| 2016 FY | 391.68 Million INR | -1.65% |
| 2016 Q2 | 364.83 Million INR | 0.0% |
| 2016 Q4 | 333.62 Million INR | 5968.13% |
| 2015 Q3 | 12.08 Million INR | -96.68% |
| 2015 FY | 398.25 Million INR | 2.91% |
| 2015 Q2 | 363.76 Million INR | 1442.01% |
| 2015 Q1 | 23.59 Million INR | -93.9% |
| 2015 Q4 | 398.25 Million INR | 3196.83% |
| 2014 Q2 | 320.17 Million INR | 3425.78% |
| 2014 FY | 387 Million INR | 30.33% |
| 2014 Q4 | 387 Million INR | 5616.54% |
| 2014 Q3 | 6.77 Million INR | -97.89% |
| 2014 Q1 | 9.08 Million INR | -96.94% |
| 2013 Q1 | 5.75 Million INR | -97.47% |
| 2013 Q3 | 5.41 Million INR | -98.01% |
| 2013 Q4 | 296.95 Million INR | 5382.84% |
| 2013 FY | 296.95 Million INR | 30.69% |
| 2013 Q2 | 272.81 Million INR | 4637.98% |
| 2012 FY | 227.2 Million INR | -14.57% |
| 2012 Q3 | 4.79 Million INR | 0.0% |
| 2012 Q4 | 227.2 Million INR | 4637.47% |
| 2011 FY | 265.97 Million INR | 57175.58% |
| 2010 FY | 464.36 Thousand INR | 763.19% |
| 2009 FY | -70.02 Thousand INR | -173.68% |
| 2008 Q4 | -25.58 Thousand INR | 0.0% |
| 2008 FY | -25.58 Thousand INR | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| ANG Lifesciences India Limited | 671.01 Million INR | -17.377% |
| Add-Shop E-Retail Limited | 116.24 Million INR | -577.532% |
| Bacil Pharma Limited | 569 Thousand INR | -138321.265% |
| BDH Industries Limited | -164.47 Million INR | 578.882% |
| Beryl Drugs Limited | 48.7 Million INR | -1517.018% |
| Cian Healthcare Limited | 544.97 Million INR | -44.524% |
| Chemo Pharma Laboratories Limited | -6.05 Million INR | 13101.271% |
| Colinz Laboratories Limited | -64.3 Million INR | 1324.853% |
| Concord Drugs Limited | 164.48 Million INR | -378.832% |
| Deccan Health Care Limited | -7.07 Million INR | 11230.822% |
| DECIPHER LABS LIMITED | -93.13 Million INR | 945.645% |
| Denis Chem Lab Limited | -236.28 Million INR | 433.333% |
| Gujarat Terce Laboratories Limited | 37.76 Million INR | -1985.629% |
| Gujarat Themis Biosyn Limited | -53.88 Million INR | 1561.69% |
| Hindustan Bio Sciences Limited | 25.21 Million INR | -3023.81% |
| Kwality Pharmaceuticals Limited | 921.75 Million INR | 14.552% |
| Makers Laboratories Limited | 172.59 Million INR | -356.349% |
| Ishita Drugs and Industries Limited | -48.09 Million INR | 1737.525% |
| Jenburkt Pharmaceuticals Limited | -791.91 Million INR | 199.457% |
| KIMIA BIOSCIENCES LIMITED | 431.72 Million INR | -82.434% |
| Medi-Caps Limited | -3.21 Million INR | 24605.818% |
| MedPlus Health Services Limited | 8.67 Billion INR | 90.925% |
| Panchsheel Organics Limited | -157.82 Million INR | 599.057% |
| Parmax Pharma Limited | 51.8 Million INR | -1420.205% |
| Patidar Buildcon Limited | 25.12 Million INR | -3034.669% |
| Sastasundar Ventures Limited | -297.24 Million INR | 364.969% |
| SHAMROCK INDUSTRIAL CO.LTD. | -9.31 Million INR | 8559.903% |
| Smruthi Organics Limited | 111.28 Million INR | -607.722% |
| Source Natural Foods and Herbal Supplements Limited | -58.58 Million INR | 1444.377% |
| SUDARSHAN PHARMA INDUSTRIES LI | 1.04 Billion INR | 24.77% |
| Trident Lifeline Limited | 117.56 Million INR | -569.97% |
| Transchem Limited | -3.16 Million INR | 25000.948% |
| Trinity League India Limited | -12 Thousand INR | 6563575.0% |
| Tyche Industries Limited | -788.94 Million INR | 199.832% |
| Vikram Thermo (India) Limited | 38.62 Million INR | -1939.138% |
| Vista Pharmaceuticals Limited | 78.7 Million INR | -900.733% |
| Vivanza Biosciences Limited | 50.02 Million INR | -1474.415% |
| Zenith Healthcare Limited | -25.45 Million INR | 3193.911% |
| Zenlabs Ethica Limited | 139.54 Million INR | -464.414% |
| Phaarmasia Limited | -4.89 Million INR | 16183.663% |
| PRAVEG LIMITED | -434.98 Million INR | 281.067% |
| Sunil Healthcare Limited | 625.4 Million INR | -25.937% |
| Syschem (India) Limited | 3.53 Million INR | -22199.462% |
| Sanjivani Paranteral Limited. | -85.95 Million INR | 1016.366% |
| Mercury Laboratories Limited | -26.72 Million INR | 3046.676% |
| SHELTER PHARMA LIMITED | -44.62 Million INR | 1865.008% |
| Vasundhara Rasayans Limited | -76.15 Million INR | 1134.256% |
| Bharat Immunologicals & Biologicals Corporation Limited | 689.39 Million INR | -14.248% |
| Roopa Industries Limited | 216.01 Million INR | -264.612% |
| PANJON LTD. | -12.8 Million INR | 6249.414% |
| Pharmaids Pharmaceuticals Limited | 37.28 Million INR | -2012.253% |
| TIAAN CONSUMER LIMITED | 13.44 Million INR | -5758.066% |
| Anuh Pharma Limited | -69.8 Million INR | 1228.278% |
| Crestchem Limited | -1.45 Million INR | 54418.414% |
| Emmessar Biotech & Nutrition Limited | -60.73 Million INR | 1396.873% |
| Sandu Pharmaceuticals Limited | -11.43 Million INR | 6990.787% |
| Fredun Pharmaceuticals Limited | 1.04 Billion INR | 24.558% |
| Trimurthi Limited | -1.17 Million INR | 66949.177% |
| Shukra Pharmaceuticals Limited | -68.26 Million INR | 1253.764% |
| Norris Medicines Limited | 214.86 Million INR | -266.57% |
| Veerhealth Care Limited | -2.38 Million INR | 33123.774% |
| Lactose (India) Limited | 373.97 Million INR | -110.609% |
| OXYGENTA PHARMACEUTICAL LIMITE | 571.32 Million INR | -37.857% |
| Ambalal Sarabhai Enterprises Limited | 132.1 Million INR | -496.228% |
| Gennex Laboratories Limited | -552.54 Million INR | 242.544% |
| Godavari Drugs Limited | 530.02 Million INR | -48.601% |
| Zenotech Laboratories Limited | -196.85 Million INR | 500.096% |
| Shree Ganesh Remedies Limited | 201.85 Million INR | -290.186% |
| Bharat Parenterals Limited | 1.48 Billion INR | 47.094% |
| Coral Laboratories Limited | -612.82 Million INR | 228.522% |
| Evoq Remedies Limited | 41.14 Million INR | -1814.108% |
| Kerala Ayurveda Limited | 447.82 Million INR | -75.875% |
| KOBO BIOTECH LIMITED | 1.39 Billion INR | 43.544% |
| Natural Capsules Limited | 956.68 Million INR | 17.672% |
| Auro Laboratories Limited | 252.51 Million INR | -211.908% |